Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Price to Earnings (2025 - 2026)

Updated

Translational Development Acquisition's Price to Earnings came in at 55.27 for Q2 2026, down 25.4% from 74.08 a year earlier but up 48.1% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Price to Earnings (2025 - 2026) Analysis & Trends

For FY2025, Translational Development Acquisition's Price to Earnings was 36.12.

  • The five-year range for quarterly Price to Earnings is 36.12 (Q4 2025) to 156.39 (Q1 2025).
  • Business Quant data shows TDACU's Price to Earnings at 37.31 (Q1 2026), 36.12 (Q4 2025) and 47.65 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.27
Mar 31, 2026 37.31
Dec 31, 2025 36.12
Sep 30, 2025 47.65
Jun 30, 2025 74.08
Mar 31, 2025 156.39
API Access

Translational Development Acquisition Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TDACU&period=max&api_key=YOUR_API_KEY